ICare4Autism: Overall Functioning in Adults With Autism Significantly Improves With Antidepressant Treatment
Repetitive Behaviors Also Significantly Decrease
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 12/07/11 -- A new study led by , Chairman of the Advisory Council of The International Center for Autism Research and Education (), demonstrates for the first time that the antidepressant fluoxetine produces an improvement in overall functioning and a decrease in repetitive behaviors in a significant number of adults with autism spectrum disorders.
The study, funded by the Orphan Products Division of the Food and Drug Administration (FDA), will be published this month in The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Its findings have important clinical implications.
Notes Dr. Hollander, Director of the Autism Spectrum Program of the / in New York City, "While research on medications for the core features of autism spectrum disorders is still in the early stages, successful treatments could greatly improve the daily lives of patients and their families."
ICare4Autism founder and CEO hailed the new study as "groundbreaking work that will lead to novel therapeutic interventions with the potential to help the vast and rapidly growing population of adults with autism all over the world."
Image Available:
Contact:
Kim Robinson
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.12.2011 - 20:47 Uhr
Sprache: Deutsch
News-ID 94884
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Family
Diese Pressemitteilung wurde bisher 224 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ICare4Autism: Overall Functioning in Adults With Autism Significantly Improves With Antidepressant Treatment"
steht unter der journalistisch-redaktionellen Verantwortung von
ICare4Autism (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
